Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
711.50    -7.50 (-1.04%)
Bid:
712.50
Ask:
714.00
Spread: 1.50 (0.211%)
Market Cap: £1.21b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

 

 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least £15m by mid-2027 for a net cash cost of £10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

 

 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

 

15.9%

4.9%

14.9%

 

 

 

Half year to 30 June 2024

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

 

18.0%

5.4%

16.7%

 

 

 

2024 FY

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

 

18.4%

4.7%

17.0%

 

 

 

 

 

 

For further information, please contact:

 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 



Date   Source Headline
16th May 20257:39 amPRNTransaction in Own Shares
15th May 20257:00 amPRNTransaction in Own Shares
13th May 20257:00 amPRNTransaction in Own Shares
12th May 20257:00 amPRNTransaction in Own Shares
9th May 20257:00 amPRNTransaction in Own Shares
8th May 20257:00 amPRNTransaction in Own Shares
7th May 20257:00 amPRNTransaction in Own Shares
6th May 20257:00 amPRNTransaction in Own Shares
2nd May 20257:00 amPRNTransaction in Own Shares
1st May 20258:05 amPRNTransaction in Own Shares
30th Apr 20257:00 amPRNTransaction in Own Shares
29th Apr 20252:35 pmPRNDirector/PDMR Shareholding
29th Apr 20252:35 pmPRNDirector/PDMR Shareholding
29th Apr 20257:00 amPRNTransaction in Own Shares
24th Apr 20259:28 amPRNHolding(s) in Company
17th Apr 20253:43 pmPRNLong-term incentive performance measures and targets
17th Apr 20257:00 amPRNTransaction in Own Shares
16th Apr 20257:00 amPRNTransaction in Own Shares
15th Apr 20259:30 amPRNAnnual Financial Report
15th Apr 20257:00 amPRNTransaction in Own Shares
14th Apr 20257:00 amPRNTransaction in Own Shares
11th Apr 20257:00 amPRNTransaction in Own Shares
10th Apr 20257:00 amPRNTransaction in Own Shares
9th Apr 20257:00 amPRNTransaction in Own Shares
8th Apr 20257:00 amPRNTransaction in Own Shares
7th Apr 202510:48 amPRNHolding(s) in Company
7th Apr 20257:00 amPRNTransaction in Own Shares
4th Apr 20257:00 amPRNTransaction in Own Shares
3rd Apr 20257:00 amPRNTransaction in Own Shares
2nd Apr 20257:00 amPRNTransaction in Own Shares
1st Apr 20257:00 amPRNTransaction in Own Shares
31st Mar 20257:00 amPRNTransaction in Own Shares
28th Mar 20257:00 amPRNTransaction in Own Shares
27th Mar 20257:00 amPRNTransaction in Own Shares
26th Mar 20257:00 amPRNTransaction in Own Shares
25th Mar 20257:00 amPRNTransaction in Own Shares
24th Mar 20253:18 pmPRNDirector Declaration
24th Mar 20253:14 pmPRNDirector/PDMR Shareholding
24th Mar 20252:59 pmPRNDirector/PDMR Shareholding
24th Mar 20257:00 amPRNTransaction in Own Shares
21st Mar 202512:40 pmPRNHolding(s) in Company
21st Mar 20257:00 amPRNTransaction in Own Shares
20th Mar 20257:00 amPRNTransaction in Own Shares
19th Mar 20257:00 amPRNTransaction in Own Shares
18th Mar 20257:00 amPRNTransaction in Own Shares
17th Mar 20257:00 amPRNTransaction in Own Shares
14th Mar 20257:15 amPRNTransaction in Own Shares
14th Mar 20257:00 amPRNFull year results for year ended 31 December 2024
13th Mar 20257:00 amPRNTransaction in Own Shares
12th Mar 20258:15 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.